Holmes Biopharma, Inc. (LMB) Reports Q3 Loss of $0.12/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/11/2026
- Wall Street ends higher as investors turn to earnings season
- Oil prices settle lower on hopes for smoother shipping in Strait of Hormuz
- The real reason Meta shares are surging has nothing to do with its new AI model
- Stifel lifts Shopify to Buy, sees agentic commerce as next growth catalyst
- Delta Air Lines stock climbs on earnings beat and strong guidance
- Almonty Industries (ALM) PT Raised to $33 at DA Davidson
- JPMorgan analysts name top short ideas for third quarter 2026
- The real reason Meta shares are surging has nothing to do with its new AI model
- Wall Street ends higher as investors turn to earnings season
- AppLovin gains market share among e-commerce advertisers
Limbach Holdings Reports Third Quarter 2017 Results
November 14, 2017 4:09 PM ESTThird Quarter 2017 Revenues of $121.3 million; Service Revenues of $25.5 million
Conference Call Scheduled for 9:00am ET Wednesday November 15, 2017
PITTSBURGH--(BUSINESS WIRE)-- Limbach Holdings, Inc. (NASDAQ: LMB) (Limbach or the Company) today announced financial results for the quarter ended September 30, 2017. Revenues increased 2.1% versus the prior year period to $121.3 million in the third quarter of 2017. Service segment revenue of $25.5 million grew 23.0% from the prior year quarter while Construction segment revenues declined 2.3% due to backlog booked in the strong second quarter that was not scheduled to commence work until after Q3.
Other key... More
